These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 18991035)

  • 41. Corneal Microstructural Changes by Confocal Microscopy in Vernal Keratoconjunctivitis Patients Treated with Topical Cyclosporine.
    Modugno RL; Scalora T; Bonaldo A; Lazzarini D; Leonardi A
    Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1599-1605. PubMed ID: 32275180
    [No Abstract]   [Full Text] [Related]  

  • 42. Efficacy of Topical Cyclosporine 0.05% the Treatment of Vernal Keratoconjunctivitis.
    Subedi K; Sharma B; Shrestha S
    Nepal J Ophthalmol; 2020 Jan; 12(23):39-47. PubMed ID: 32799238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study.
    Pucci N; Caputo R; di Grande L; de Libero C; Mori F; Barni S; di Simone L; Calvani A; Rusconi F; Novembre E
    Pediatr Allergy Immunol; 2015 May; 26(3):256-261. PubMed ID: 25712437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vernal shield ulcers treated with frequently installed topical cyclosporine 0.05% eyedrops.
    Westland T; Patryn EK; Nieuwendaal CP; van der Meulen IJE; Mourits MP; Lapid-Gortzak R
    Int Ophthalmol; 2018 Feb; 38(1):363-368. PubMed ID: 28120172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Topical cyclosporine in vernal keratoconjunctivitis.
    Bleik JH; Tabbara KF
    Ophthalmology; 1991 Nov; 98(11):1679-84. PubMed ID: 1800929
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathogenesis of Vernal Keratoconjunctivitis and Associated Factors.
    Nebbioso M; Zicari AM; Celani C; Lollobrigida V; Grenga R; Duse M
    Semin Ophthalmol; 2015; 30(5-6):340-4. PubMed ID: 24571721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topical tacrolimus 0.03% as sole therapy in vernal keratoconjunctivitis: a randomized double-masked study.
    Müller GG; José NK; de Castro RS
    Eye Contact Lens; 2014 Mar; 40(2):79-83. PubMed ID: 24418865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of a Cationic Emulsion of Cyclosporine in Moderate Vernal Keratoconjunctivitis.
    Caputo R; Di Grande L; de Libero C; Marziali E; Mori F; Masini M
    Cornea; 2024 Feb; 43(2):228-232. PubMed ID: 37747690
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study.
    Virtanen HM; Reitamo S; Kari M; Kari O
    Acta Ophthalmol Scand; 2006 Oct; 84(5):693-5. PubMed ID: 16965503
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of 2% Rebamipide Suspension for Vernal Keratoconjunctivitis: A Clinical Comparison with Topical Immune Modulators Cyclosporine and Tacrolimus.
    Malhotra C; Singh H; Jain AK; Gupta A; Ram J
    Ocul Immunol Inflamm; 2022 Jul; 30(5):1083-1091. PubMed ID: 33764241
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Retrospective review on the use of topical cyclosporin a 0.05% for paediatric allergic conjunctivitis in Hong Kong Chinese.
    Wu MM; Yau GS; Lee JW; Wong AL; Tam VT; Yuen CY
    ScientificWorldJournal; 2014; 2014():396987. PubMed ID: 25386595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tacrolimus in Corticosteroid-Refractory Vernal Keratoconjunctivitis.
    Chatterjee S; Agrawal D
    Cornea; 2016 Nov; 35(11):1444-1448. PubMed ID: 27310883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis.
    Hu Y; Matsumoto Y; Dogru M; Okada N; Igarashi A; Fukagawa K; Tsubota K; Fujishima H
    Allergy; 2007 Aug; 62(8):917-25. PubMed ID: 17620070
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Case of Shield Ulcer Due to Vernal Keratoconjunctivitis.
    Özkaya D; Usta G; Karaca U
    Iran J Allergy Asthma Immunol; 2021 Aug; 20(4):505-508. PubMed ID: 34418905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surgical debridement plus topical cyclosporine A in the treatment of vernal shield ulcers.
    Caputo R; Pucci N; Mori F; De Libero C; Di Grande L; Bacci GM
    Int J Immunopathol Pharmacol; 2012; 25(3):775-80. PubMed ID: 23058030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topical tacrolimus for the treatment of severe allergic keratoconjunctivitis in children.
    Liendo VL; Vola ME; Barreiro TP; Wakamatsu TH; Gomes JÁP; Santos MSD
    Arq Bras Oftalmol; 2017; 80(4):211-214. PubMed ID: 28954018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monotherapy of topical tacrolimus 0.03% in the treatment of vernal keratoconjunctivitis in the pediatric population.
    Samyukta SK; Pawar N; Ravindran M; Allapitchai F; Rengappa R
    J AAPOS; 2019 Feb; 23(1):36.e1-36.e5. PubMed ID: 30664932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral cyclosporine therapy for refractory severe vernal keratoconjunctivitis.
    Gokhale NS; Samant R; Sharma V
    Indian J Ophthalmol; 2012; 60(3):220-3. PubMed ID: 22569387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A.
    Brignole F; Pisella PJ; De Saint Jean M; Goldschild M; Goguel A; Baudouin C
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):90-5. PubMed ID: 11133852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of vernal keratoconjunctivitis: Navigating a changing treatment landscape.
    Ali A; Bielory L; Dotchin S; Hamel P; Strube YNJ; Koo EB
    Surv Ophthalmol; 2024; 69(2):265-278. PubMed ID: 37890678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.